HUP0302571A2 - Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére - Google Patents

Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére

Info

Publication number
HUP0302571A2
HUP0302571A2 HU0302571A HUP0302571A HUP0302571A2 HU P0302571 A2 HUP0302571 A2 HU P0302571A2 HU 0302571 A HU0302571 A HU 0302571A HU P0302571 A HUP0302571 A HU P0302571A HU P0302571 A2 HUP0302571 A2 HU P0302571A2
Authority
HU
Hungary
Prior art keywords
treatment
pharmaceutical composition
composition containing
organic compounds
containing mixture
Prior art date
Application number
HU0302571A
Other languages
English (en)
Inventor
Bernard Cuenoud
Robin Alec Fairhurst
Nicholas Lowther
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HUP0302571A2 publication Critical patent/HUP0302571A2/hu
Publication of HUP0302571A3 publication Critical patent/HUP0302571A3/hu
Publication of HU229552B1 publication Critical patent/HU229552B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A találmány tárgya egy gyógyászati készítmény, amely külön vagy együtttartalmazza (A) (I) képlet szerinti vegyületet szabad vagygyógyszerészetileg tolerálható só vagy szolvát formájában és (B)kortikoszteroidot szimultán, szakaszos vagy szeparált adagolásragyulladásos vagy obstruktív légúti megbetegedések kezelésére, az (A)és (B) moláris aránya 100:1 - 1:300. Ó
HU0302571A 2000-12-04 2001-12-03 Pharmaceutical composition containing mixture of organic compounds for the treatment of air way diseases HU229552B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029562.6A GB0029562D0 (en) 2000-12-04 2000-12-04 Organic compounds
PCT/EP2001/014122 WO2002045703A2 (en) 2000-12-04 2001-12-03 Mixtures or organic compounds for the treatmentof airway diseases

Publications (3)

Publication Number Publication Date
HUP0302571A2 true HUP0302571A2 (hu) 2003-11-28
HUP0302571A3 HUP0302571A3 (en) 2005-05-30
HU229552B1 HU229552B1 (en) 2014-01-28

Family

ID=9904414

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302571A HU229552B1 (en) 2000-12-04 2001-12-03 Pharmaceutical composition containing mixture of organic compounds for the treatment of air way diseases

Country Status (28)

Country Link
US (5) US6800643B2 (hu)
EP (2) EP1341542B1 (hu)
JP (2) JP2004514739A (hu)
KR (1) KR100523541B1 (hu)
CN (1) CN1212119C (hu)
AT (1) ATE361077T1 (hu)
AU (2) AU1708202A (hu)
BR (1) BRPI0115910B8 (hu)
CA (1) CA2427282C (hu)
CY (1) CY1106727T1 (hu)
CZ (1) CZ304294B6 (hu)
DE (1) DE60128258T2 (hu)
DK (1) DK1341542T3 (hu)
EC (1) ECSP034620A (hu)
ES (1) ES2284732T3 (hu)
GB (1) GB0029562D0 (hu)
HK (1) HK1059564A1 (hu)
HU (1) HU229552B1 (hu)
IL (2) IL155709A0 (hu)
MX (1) MXPA03004976A (hu)
NO (1) NO325692B1 (hu)
NZ (1) NZ525731A (hu)
PL (1) PL204002B1 (hu)
PT (1) PT1341542E (hu)
RU (1) RU2292890C2 (hu)
SK (1) SK287331B6 (hu)
WO (1) WO2002045703A2 (hu)
ZA (1) ZA200303399B (hu)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
US20040146509A1 (en) * 2002-07-25 2004-07-29 Zhihe Li Methods for improvement of lung function using TGF-beta inhibitors
PA8578101A1 (es) 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
US7250426B2 (en) * 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
PE20100399A1 (es) * 2003-04-02 2010-06-01 Novartis Ag Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas
EP1613315B1 (en) * 2003-04-04 2009-01-21 Novartis AG Quinoline-2-one-derivatives for the treatment of airways diseases
GB0307856D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
MX2007001903A (es) 2004-08-20 2007-08-02 Mannkind Corp Catalisis de sintesis de dicetopiperazina.
KR101306384B1 (ko) 2004-08-23 2013-09-09 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염
KR100666220B1 (ko) * 2005-01-31 2007-01-09 영남대학교 산학협력단 구내염 치료용 분사제 조성물
JP2008534611A (ja) * 2005-03-30 2008-08-28 シェーリング コーポレイション 抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法
GB0511065D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200744612A (en) * 2005-08-26 2007-12-16 Astrazeneca Ab New combination
JP5465878B2 (ja) 2005-09-14 2014-04-09 マンカインド コーポレイション 活性薬剤に対する結晶性微粒子表面の親和性を増大させることに基づく薬物処方の方法
GB0523655D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
EP1971346A2 (en) * 2005-12-20 2008-09-24 Tika Läkemedel AB Systems and methods for the delivery of corticosteroids
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US20070225233A1 (en) * 2006-03-27 2007-09-27 Tsu-Fuh Yeh Reducing the risk of chronic lung disease in infants
PT2044025E (pt) 2006-06-30 2012-12-17 Novartis Ag Derivados de quinolinona e suas composições farmacêuticas
EP1878722A1 (en) * 2006-07-13 2008-01-16 Novartis AG Quinolinone derivatives and their pharmaceutical compositions
EP2230934B8 (en) 2007-12-14 2012-10-24 AeroDesigns, Inc Delivering aerosolizable food products
CN104689432B (zh) 2008-06-13 2018-07-06 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
CN107412212B (zh) 2009-05-29 2021-01-22 珍珠治疗公司 经肺递送长效毒蕈碱拮抗剂及长效β2肾上腺素能受体激动剂的组合物及相关方法与系统
EP2440184B1 (en) 2009-06-12 2023-04-05 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
KR100940388B1 (ko) * 2009-07-01 2010-02-02 유병덕 스크류탈수기 및 이를 포함하는 유기성폐기물 건조장치
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
WO2012007729A2 (en) * 2010-07-16 2012-01-19 Cipla Limited Pharmaceutical compositions
WO2012049444A1 (en) 2010-10-12 2012-04-19 Cipla Limited Pharmaceutical composition
DK2694402T3 (en) 2011-04-01 2017-07-03 Mannkind Corp BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CN102247380A (zh) * 2011-08-19 2011-11-23 北京阜康仁生物制药科技有限公司 一种以布地奈德与茚达特罗为活性成分的复方制剂
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
WO2013132514A2 (en) * 2012-03-09 2013-09-12 Rao Davuluri Ramamohan A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one
WO2014008639A1 (zh) * 2012-07-11 2014-01-16 上海威智医药科技有限公司 制备茚达特罗的方法
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014044288A1 (en) * 2012-09-21 2014-03-27 Crystal Pharma Sa Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
BR112016000937A8 (pt) 2013-07-18 2021-06-22 Mannkind Corp formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
ITUB20153978A1 (it) * 2015-09-28 2017-03-28 Laboratorio Chimico Int S P A Procedimento per la preparazione di derivati di indanammina e di nuovi intermedi di sintesi.
CN107868045A (zh) * 2016-09-28 2018-04-03 四川海思科制药有限公司 一种茚达特罗中间体的制备方法
CN106831445B (zh) * 2016-11-22 2019-01-22 斯芬克司药物研发（天津）股份有限公司 一种茚基胺化合物的制备方法
CN110229078A (zh) * 2019-05-22 2019-09-13 博诺康源(北京)药业科技有限公司 一种茚达特罗起始原料开环杂质的制备
CN114751857A (zh) * 2022-04-29 2022-07-15 梯尔希（南京）药物研发有限公司 一种茚达特罗杂质的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
WO1993018007A1 (en) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Novel carbostyril derivative
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
ATE253908T1 (de) * 1995-08-16 2003-11-15 Huntington Medical Res Inst Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs
GB9603237D0 (en) * 1996-02-16 1996-04-17 Sandoz Ltd Organic compounds
TW375604B (en) 1996-02-19 1999-12-01 Kissei Pharmaceutical 3,4-di-substituting phenyl-ethanolamine-tetrahydronaphthyl carboxylic amide derivatives
GB9610122D0 (en) 1996-05-15 1996-07-24 Reckitt & Colmann Prod Ltd Organic compositions
EP0997458A4 (en) 1997-07-03 2003-03-05 Asahi Chemical Ind NOVEL TRICYCLIC COMPOUNDS HAVING SATUROUS CORES AND MEDICINAL COMPOSITIONS CONTAINING THEM
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60128258T2 (de) 2007-12-27
CY1106727T1 (el) 2012-05-23
SK6502003A3 (en) 2003-12-02
NO325692B1 (no) 2008-07-07
US7622484B2 (en) 2009-11-24
EP1772142A2 (en) 2007-04-11
CN1212119C (zh) 2005-07-27
KR100523541B1 (ko) 2005-10-25
NZ525731A (en) 2004-11-26
IL155709A (en) 2008-11-26
RU2292890C2 (ru) 2007-02-10
NO20032510D0 (no) 2003-06-03
PT1341542E (pt) 2007-08-01
PL362443A1 (en) 2004-11-02
MXPA03004976A (es) 2003-09-05
EP1772142A3 (en) 2011-09-14
NO20032510L (no) 2003-06-03
ECSP034620A (es) 2003-06-25
DE60128258D1 (de) 2007-06-14
US6800643B2 (en) 2004-10-05
US20100068288A1 (en) 2010-03-18
JP2007302684A (ja) 2007-11-22
ATE361077T1 (de) 2007-05-15
CA2427282C (en) 2010-10-19
CA2427282A1 (en) 2002-06-13
RU2003119549A (ru) 2005-02-10
SK287331B6 (sk) 2010-07-07
US20050009795A1 (en) 2005-01-13
US20040038951A1 (en) 2004-02-26
WO2002045703A3 (en) 2003-03-13
IL155709A0 (en) 2003-11-23
US20120108555A1 (en) 2012-05-03
KR20030048065A (ko) 2003-06-18
EP1341542A2 (en) 2003-09-10
EP1341542B1 (en) 2007-05-02
CZ304294B6 (cs) 2014-02-19
AU2002217082B2 (en) 2005-04-07
BR0115910A (pt) 2004-01-20
HU229552B1 (en) 2014-01-28
US20060052352A1 (en) 2006-03-09
BRPI0115910B8 (pt) 2021-05-25
HK1059564A1 (en) 2004-07-09
ES2284732T3 (es) 2007-11-16
HUP0302571A3 (en) 2005-05-30
CN1477963A (zh) 2004-02-25
DK1341542T3 (da) 2007-09-03
CZ20031537A3 (cs) 2003-10-15
WO2002045703A2 (en) 2002-06-13
ZA200303399B (en) 2004-04-23
JP2004514739A (ja) 2004-05-20
PL204002B1 (pl) 2009-12-31
US7008951B2 (en) 2006-03-07
AU1708202A (en) 2002-06-18
BRPI0115910B1 (pt) 2019-12-31
GB0029562D0 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
HUP0302571A2 (hu) Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére
MY139577A (en) Anti-inflammatory androstane derivative
HUP0103108A2 (hu) Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére
HUP0003848A2 (hu) Budesonid és formoterol új alkalmazása
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
MEP49308A (en) Once-a-day oxycodone formulations
GB9902689D0 (en) Organic compounds
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
SE9901573D0 (sv) New compounds
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
SE0102440D0 (sv) New compound
SE0101322D0 (sv) Novel compounds
SE9901572D0 (sv) New compounds
HUP0400495A2 (hu) Apomorfin szájnyálkahártyán keresztül történő adagolására szolgáló orális készítmény
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
BR0011094A (pt) Polimorfos de um citrato cristalino de azobiciclo[2,2,2]octan-3-amina e suas composições farmacêuticas
ATE301997T1 (de) Antivirale therapie
DE60202299D1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
DE60104288D1 (de) Antivirale therapie
HUP0301957A2 (hu) Karbaminsav-észterek mint Xa-faktor inhibitorok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
HUP0100122A2 (hu) Tiludronsav és származékai alkalmazása szárnyasok csontritkulásának megelőzésére és kezelésére szolgáló gyógyászati készítmény előállítására
UY25339A1 (es) Procedimiento para la preparacion de medicamentos conteniendo compuestos utilizados en el tratamiento del sindrome de la apnea del sueño.